The main protease of SARS-CoV-2 downregulates innate immunity via a translational repression

Signal Transduct Target Ther. 2023 Apr 13;8(1):162. doi: 10.1038/s41392-023-01418-3.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / genetics
  • Humans
  • Immunity, Innate / genetics
  • Peptide Hydrolases
  • Protein Processing, Post-Translational
  • SARS-CoV-2*

Substances

  • Peptide Hydrolases